SS
COGT icon

SBI Securities’s Cogent Biosciences COGT Stock Holding History

SBI Securities’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39 Hold
1
– – ﹤0.01% 3723
2026
Q1 		$38 Hold
1
– – ﹤0.01% 3629
2025
Q4 		$36 Sell
1
-93
-99% -$2.61K ﹤0.01% 3644
2025
Q3 		$1.35K Buy
94
+1
+1% +$12 ﹤0.01% 2574
2025
Q2 		$668 Hold
93
– – ﹤0.01% 2846
2025
Q1 		$557 Hold
93
– – ﹤0.01% 2826
2024
Q4 		$725 Buy
+93
New +$927 ﹤0.01% 2750

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SBI Securities's COGT Position: Q2 2026 in Review

SBI Securities held its Cogent Biosciences (COGT) position steady in Q2 2026 at 1 share worth $39. The position accounts for ﹤0.01% of the portfolio, ranked #3723.

SBI Securities first reported a position in COGT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.35K in Q3 2025. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • SBI Securities held 1 share of Cogent Biosciences worth $39 as of Q2 2026.
  • SBI Securities left its Cogent Biosciences share count unchanged in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3723 holding.
  • SBI Securities first reported a position in Cogent Biosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Cogent Biosciences position peaked at $1.35K in Q3 2025.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.